Evaluate Eplontersen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Eplontersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Eplontersen Today - Breaking & Trending Today

Ionis' antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting

Published: June 10, 2021

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced that multiple presentations highlighting...

Source: prnewswire.com

Related Topics:

C Frank BennettSami KhellaKemi OlugemoArthurk AsburyNick VineyPeripheral Nerve SocietyIonis Pharmaceuticals IncPenn Presbyterian Medical CenterIonis PharmaceuticalsNerve SocietyAnnual MeetingFrank BennettPenn Presbyterian MedicalAntisense TherapiesNeurological DiseasesEvaluate EplontersenAntisense OligonucleotideTransthyretin Gene MutationsPolyneuropathy ManifestationsHereditary TransthyretinTransthyretin AmyloidosisSafety WithInotersen TreatmentHereditary Transthyretin Amyloid PolyneuropathyTransthyretin Variant